Trademark Overview
On Tuesday, September 17, 2024, a trademark application was filed for ICAT with the United States Patent and Trademark Office. The USPTO has given the ICAT trademark a serial number of 98754433. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, September 17, 2024. This trademark is owned by Biohaven Therapeutics Ltd.. The ICAT trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations and substances for the treatment of neurological, neuropsychiatric, neurodegenerative, viral, metabolic, obesity, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, osteogenesis, immune system, central nervous system, peripheral nervous system, and voluntary muscle movement related diseases and disorders
Research, development, discovery, testing, and collaboration for others of pharmaceutical drugs to treat diseases using a proprietary drug discovery platform